UpPharm All articles
Medicare & Insurance

Your 2026 Part D Checkup: What Medicare’s New Drug Prices Mean at the Pharmacy Counter

UpPharm
Your 2026 Part D Checkup: What Medicare’s New Drug Prices Mean at the Pharmacy Counter

Starting January 1, 2026, Medicare’s first negotiated drug prices took effect. If you take one of the selected medicines — or you help a family member manage Part D — this is the first year you can see what the change means at the pharmacy counter. The short version: the new prices can lower what plans pay and may lower what you pay, but they do not turn every prescription into a flat, predictable copay. You still need to check your plan.

What Medicare actually negotiated

Medicare used its new authority to negotiate a maximum fair price with drugmakers for 10 drug products. Think of that price as a ceiling on what manufacturers can charge Part D plans for those drugs. It is not a national retail sticker price, and it is not automatically your copay.

The first group covers some familiar categories:

Several of these medicines are also known by generic name. Apixaban is Eliquis. Rivaroxaban is Xarelto. Empagliflozin is Jardiance. Dapagliflozin is Farxiga. Sitagliptin is Januvia. Sacubitril/valsartan is Entresto. Etanercept is Enbrel. Ustekinumab is Stelara. Ibrutinib is Imbruvica. Insulin aspart is the active ingredient in NovoLog and Fiasp. If your bottle uses the generic name, you may still be affected.

What a negotiated price does — and does not — guarantee

On the plus side, a lower manufacturer price can reduce what a Part D plan spends. Plans may pass some of that savings along through premiums or cost sharing. For people who take these drugs, that could mean a lower copay or coinsurance than they would have seen otherwise.

But your out-of-pocket cost is still set by your specific plan. A negotiated price does not guarantee:

Your cost depends on the plan’s formulary, the drug’s tier, whether you have a deductible, whether your share is a flat copay or a percentage coinsurance, whether you use a preferred pharmacy, and whether you fill a 30-day or 90-day supply. In 2026, the Part D out-of-pocket cap is $2,100, and the maximum deductible is $615. The cap is real protection for covered drugs, but it does not make every drug covered or free.

A before-you-fill checklist

Use this list before you refill a selected drug — or any expensive Part D medicine.

  1. Find your plan’s 2026 formulary. Search the exact drug name, strength, and form. A plan may cover one strength but not another.
  2. Check the tier. A lower tier usually means a lower share, but not always.
  3. Ask whether the deductible applies. Some plans waive it for certain tiers; others do not.
  4. Find out if your share is a copay or coinsurance. A percentage can change when the drug price changes.
  5. Ask about utilization management. Prior authorization, step therapy, and quantity limits can delay a fill even when the drug is covered.
  6. Confirm the pharmacy. Preferred pharmacies can have a different price than standard network pharmacies.
  7. Ask for the out-the-door number. Say: What will I pay today, including any deductible?
  8. Compare 30-day and 90-day fills. The lower monthly price is not always the lower total.
  9. Ask about alternatives. A different drug in the same class may be cheaper on your plan.
  10. Check whether you qualify for Extra Help or the Medicare Prescription Payment Plan. Extra Help lowers costs for people with limited income and resources. The payment plan spreads out your out-of-pocket costs over the year.

Questions to ask your pharmacist

Pharmacists cannot change your plan’s formulary, but they can help you read it and avoid surprises. Good questions:

Where to check before you go

Start with your plan’s website or app and its 2026 formulary. Medicare Plan Finder at Medicare.gov can compare plans, and 1-800-MEDICARE can answer questions. Keep your Explanation of Benefits and pharmacy receipts. If a price looks wrong, ask the plan and the pharmacy to walk through the claim.

Medicare Open Enrollment runs through December 7, so if you are already thinking about next year, compare 2027 plans with your drug list in hand. The negotiated prices are a meaningful change, but they are one layer of a system with many moving parts. The best defense is a specific question and a written answer.

All Articles

Related Articles

Extra Strength, PM, or Extended Release? How to Read an OTC Box Without Guessing

Extra Strength, PM, or Extended Release? How to Read an OTC Box Without Guessing